# Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC

> **NCT02143492** · — · COMPLETED · sponsor: **Argos Therapeutics** · enrollment: 11 (actual)

## Conditions studied

- Kidney Cancer
- Renal Cell Carcinoma
- Advanced Renal Cell Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02143492
- **Lead sponsor:** Argos Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2017-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02143492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02143492, "Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02143492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*